Deferred Tax Assets, Net of Valuation Allowance of LISATA THERAPEUTICS, INC. from 31 Dec 2010 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary: LISATA THERAPEUTICS, INC. quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 31 Dec 2010 to 31 Dec 2024.
LISATA THERAPEUTICS, INC. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 31 Dec 2024 was $27,794,000, a 18% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)

LISATA THERAPEUTICS, INC. Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$27,794,000	+$4,272,000	+18%	31 Dec 2024	10-K	27 Feb 2025	2024	FY
Q4 2023	$23,522,000			31 Dec 2023	10-K	27 Feb 2025	2024	FY
Q4 2017	$66,696,000	-$36,669,000	-35%	31 Dec 2017	10-K	22 Mar 2018	2017	FY
Q4 2016	$103,365,000	-$5,193,700	-4.8%	31 Dec 2016	10-K	22 Mar 2018	2017	FY
Q4 2015	$108,558,700	+$20,985,700	+24%	31 Dec 2015	10-K	17 Mar 2017	2016	FY
Q4 2014	$87,573,000	+$48,428,300	+124%	31 Dec 2014	10-K	15 Mar 2016	2015	FY
Q4 2013	$39,144,700	$0	0%	31 Dec 2013	10-K	15 Mar 2016	2015	FY
Q4 2012	$39,144,700	+$16,619,900	+74%	31 Dec 2012	10-K	02 Mar 2015	2014	FY
Q4 2011	$22,524,800	+$2,363,800	+12%	31 Dec 2011	10-K	11 Mar 2013	2012	FY
Q4 2010	$20,161,000			31 Dec 2010	8-K	15 Aug 2012	2011	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.